Data / Form D filings / Spear Bio Inc.
Spear Bio Inc.: Form D filings
Spear Bio Inc., a biotechnology company in Woburn, MA, filed 4 Form D notices with the SEC between 2021 and 2024. The latest, on August 5, 2024, reports $45 million sold of a $45 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 Tradecenter Dr., Suite 510, Woburn, MA, 01801
- Phone
- (978) 406-1169
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1852708
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 5, 2024 | New notice | $44,999,997 | $44,999,997 | 8 | Jul 23, 2024 | sec.gov | |
| Oct 18, 2022 | New notice | $3,000,000 | $2,391,188 | $608,812 | 5 | Oct 11, 2022 | sec.gov |
| Oct 14, 2021 | New notice | $10,000,000 | $1,571,429 | $8,428,571 | 3 | Sep 30, 2021 | sec.gov |
| Mar 26, 2021 | New notice | $1,200,000 | $1,100,000 | $100,000 | 4 | Mar 15, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Feng Xuan | Executive Officer, Director | |
| John Wu | Executive Officer | |
| David Singer | Director | |
| Peng Yin | Director | |
| Wen Chan | Director | |
| Vikram Bajaj | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Aug 5, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Spear Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.